Euronanomed III - Euronanomed III

Targeting breast tumors with anti-Netrin-1 nanocarriers as a promoter of immunity ? – NanoNET

Project coordinator

Monsieur Patrick MEHLEN (Centre de Recherche en Cancérologie de Lyon)

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.

Partner

CRCL Centre de Recherche en Cancérologie de Lyon
Academia Sinica
Istituto Oncologico Veneto IOV-IRCCS
NETRIS PHARMA

Help of the ANR 264,448 euros
Beginning and duration of the scientific project: March 2020 - 36 Months

Useful links

Explorez notre base de projets financés

 

 

ANR makes available its datasets on funded projects, click here to find more.

Sign up for the latest news:
Subscribe to our newsletter